Skip to Content

Bromday Approval History

FDA Approved: Yes (Discontinued) (First approved October 16, 2010)
Brand name: Bromday
Generic name: bromfenac
Dosage form: Ophthalmic Solution
Previous Name: XiDay
Company: Bausch & Lomb Inc.
Treatment for: Postoperative Ocular Inflammation

Marketing Status: Discontinued

Bromday (bromfenac ophthalmic solution) is a once-daily ocular nonsteroidal anti-inflammatory agent for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.

Development History and FDA Approval Process for Bromday

DateArticle
Oct 20, 2010Approval ISTA Pharmaceuticals Receives FDA Approval for Bromday
Mar  9, 2010ISTA Pharmaceuticals Receives Action Date for FDA Review of Once-Daily XiDay
Dec 23, 2009ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once-Daily XiDay

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide